CIK 0001540159
- Non-accelerated filer
- Smaller reporting company
Edesa Biotech, Inc.
Sign in to watch- Ticker
- EDSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- Phone
- +1 905-475-1234
- Business address
- C/O FASKEN MARTINEAU DUMOULIN LLP, 333 BAY STREET, SUITE 2400, TORONTO, Ontario, Canada, M5H 2T6
- Former names
- Stellar Biotechnologies, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.83 | $2K | 2,120,024 |
| 2020-03-17 | Nijhawan Pardeep Chief Executive Officer | Purchase | +1,000 | $1.90 | $2K | 2,121,024 |
| 2020-01-08 | van der Velden Peter Director | Purchase | +128,722 | $3.20 | $412K | 1,833,066 |
| 2020-01-08 | van der Velden Peter Director | Purchase | +11,903 | $3.20 | $38K | 169,502 |
| 2020-01-08 | Sistilli Carlo Director | Purchase | +2,436 | $4.11 | $10K | 2,436 |
| 2020-01-08 | JOHNSON LORIN K Director | Purchase | +8,524 | $4.11 | $35K | 8,524 |
| 2020-01-08 | Brooks Michael J President | Purchase | +1,827 | $4.11 | $8K | 1,827 |
Page 3 of 3 · 47 trades